Newsroom

Home/Newsroom/

Jess Ly Runs for the Cause – A Half Marathon for the LRG & GIST Awareness

During the pandemic and in September 2020, Jess Ly was diagnosed with GIST cancer. The Life Raft Group (LRG) community, her GIST friends, and the cancer community welcomed her with open arms. Now she's running a half marathon to raise awareness and funds for #GISTresearch!

By |2022-10-14T09:39:40-04:00October 7th, 2022|Advocacy, Events, Fundraising, News|

Collaborative Effort Produces Position Paper on Need for Advanced Biomarker Testing

The Life Raft Group was recently part of team of authors on a collaborative position paper entitled 'Undetected KIT and PDGFRA mutations: an under-recognised cause of gastrointestinal stromal tumours (GISTs) incorrectly classified as wild-type published' in Pathology: The Journal of the Royal College of Pathologists of Australia.

By |2022-08-15T16:05:39-04:00August 15th, 2022|Mutational Testing, News, Research|

Life Fest 2022: The Role of Surgery in GIST Treatment/Neoadjuvant & Adjuvant Therapy

Dr. Jason SIcklick, UC San Diego Moores Cancer Center presented The Role of Surgery in GIST Treatment/Neoadjuvant & Adjuvant Therapy at Life Fest 2022 in New Orleans.

By |2022-10-07T09:19:09-04:00August 10th, 2022|Events, Video|
Go to Top